Lessons from negative dyspnoea studies: arguments for the multidimensional evaluation of multidirectional therapeutic approaches
- PMID: 30655454
- DOI: 10.1183/13993003.02471-2018
Lessons from negative dyspnoea studies: arguments for the multidimensional evaluation of multidirectional therapeutic approaches
Conflict of interest statement
Conflict of interest: T. Similowski reports personal fees and non-financial support from Novartis, and personal fees from AstraZeneca, Boerhinger Ingelheim France, GSK, Lungpacer Inc., TEVA, Chiesi, Pierre Fabre and Invacare, outside the submitted work; and in addition, has a patent about a “brain-ventilator interface to improve the detection of dyspnoea” licensed to Air Liquide Medical Systems and MyBrainTechnology. Conflict of interest: L. Serresse has nothing to disclose.
Comment on
-
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.Eur Respir J. 2019 Jan 17;53(1):1801270. doi: 10.1183/13993003.01270-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30361250 Clinical Trial.
-
A musical intervention for respiratory comfort during noninvasive ventilation in the ICU.Eur Respir J. 2019 Jan 17;53(1):1801873. doi: 10.1183/13993003.01873-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30578396 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical